Apoptosis machinery

The apoptosis machinery refers to the complex network of proteins and signaling pathways responsible for executing programmed cell death, a vital process for maintaining tissue homeostasis and eliminating damaged or potentially cancerous cells [1, 3]. It is broadly divided into the intrinsic (mitochondrial) pathway, regulated by the Bcl-2 family of proteins, and the extrinsic (death receptor) pathway, initiated by extracellular ligands [2, 11]. Key components include the caspase family of proteases, which act as the executioners of the cell, and various regulatory proteins like IAPs and Apaf-1 [6, 9]. In many diseases, particularly cancer, the apoptosis machinery is dysregulated, allowing cells to evade death and proliferate uncontrollably [2, 8]. Therapeutic strategies aim to restore or bypass these defects using small molecules like BH3 mimetics or biologics like death receptor agonists to selectively trigger cell death in pathological tissues [3, 12]. Modern therapeutic interventions, such as BH3 mimetics (e.g., venetoclax) and IAP inhibitors, are designed to directly reactivate this machinery to induce selective tumor cell death [3, 12].

Other names

Core apoptotic machineryApoptotic signaling pathwayProgrammed cell death machineryApoptotic cascade

Drugs targeting the apoptosis machinery function by restoring the cell's innate ability to undergo programmed death. This is achieved through several mechanisms: inhibiting anti-apoptotic Bcl-2 family proteins (BH3 mimetics), antagonizing Inhibitors of Apoptosis Proteins (IAP inhibitors), or activating death receptors (DR4/5 agonists) [3, 8]. These interventions ultimately lead to the activation of initiator and executioner caspases, which proteolytically degrade cellular components [6, 9].